Manager TitleAgeSince
Chief Executive Officer 64 -
Director of Finance/CFO 61 -
Chief Operating Officer 60 -
Director TitleAgeSince
Chairman 64 -
Director/Board Member 61 -
Director/Board Member 60 -
Date Insider Type Main position Quantity % Market Cap.
02/03/21Buy

Director

10,000 0.0833%
25/02/21
Pipv Capital
OtherCompany 3,350,000 111.6667%
25/02/21
Pipv Capital
OtherCompany 3,350,000 111.6667%
Change 5-day change 1-year change 3-year change Capi.($)
-0.29%+0.10% - - 176M
-14.48%-9.83% - - 1.14B
+6.36%-4.87% - - 850M
0.00%+0.30% - - 643M
+1.36%+6.20% - - 663M
+0.19%-0.65% - - 609M
-0.34%-0.29% - - 599M
-0.10%+0.10% - - 596M
-2.70%-11.38%+274.03%-71.20% 597M
Average -1.11%-1.20%+274.03%-71.20% 712.26M
Weighted average by Cap. -2.05%-0.89%+274.03%-71.20%
Logo Ibere Pharmaceuticals
Ibere Pharmaceuticals is a blank check company. The Company is created for the purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company focuses on healthcare sector. The Company has no operations and has not generated revenues.
Employees
-
  1. Stock Market
  2. Stocks
  3. IBER Stock